SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

MBX Biosciences, Inc. (MBX)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Probe Score
1.5 / 10
Letters
1
Latest Activity
Sep. 22, 2025
Version
v1

Score Breakdown

Letter Count
1.0
Sentiment / Tone
0.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Sep. 22, 2025 CORRESP Neutral/Informational Moderate MBX Biosciences, Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-1. They are seeking to have the regis… Read Filing EDGAR
Sep. 22, 2025 CORRESP Neutral/Informational Moderate The correspondence from J.P. Morgan Securities LLC and Jefferies LLC to the SEC is a formal request for the acceleration of the effective date of MBX Biosciences, Inc.'s Registrat… Read Filing EDGAR
Aug. 13, 2025 UPLOAD Neutral/Informational Low The SEC correspondence dated August 13, 2025, informs P. Kent Hawryluk, CEO of MBX Biosciences, Inc., that the SEC does not intend to review their draft registration statement sub… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.